|
🦁
|
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
S. Zucker,
Jian Cao,
Wen‐Tien Chen
|
9 |
2000 |
9
🦁
|
|
🦁
|
Role of matrix metalloproteinases (MMPs) in colorectal cancer
S. Zucker,
J. Vacirca
|
8 |
2004 |
8
🦁
|
|
🐬
|
Stimulation of Matrix Metalloproteinase Production by Recombinant Extracellular Matrix Metalloproteinase Inducer from Transfected Chinese Hamster Ovary Cells*
Huiming Guo,
S. Zucker,
M. Gordon,
B. Toole,
C. Biswas
|
8 |
1997 |
8
🐬
|
|
🦁
|
Mr 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer
S. Zucker,
R. Lysik,
M. Zarrabi,
U. Moll
|
8 |
1993 |
8
🦁
|
|
🦁
|
Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP)*
9 auth.
S. Zucker,
M. Drews,
Cathleen Conner,
H. Foda,
Y. DeClerck,
K. Langley,
...
W. Bahou,
A. Docherty,
Jian Cao
|
8 |
1998 |
8
🦁
|
|
🦁
|
Tumorigenic potential of extracellular matrix metalloproteinase inducer.
9 auth.
S. Zucker,
Michelle Hymowitz,
E. Rollo,
R. Mann,
Cathleen Conner,
Jian Cao,
...
H. Foda,
D. Tompkins,
B. Toole
|
8 |
2001 |
8
🦁
|
|
🐢
|
Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis.
H. Foda,
S. Zucker
|
8 |
2001 |
8
🐢
|
|
🐬
|
Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression
Li Yan,
S. Zucker,
B. Toole
|
8 |
2005 |
8
🐬
|
|
🐬
|
Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.
H. Kataoka,
R. DeCastro,
S. Zucker,
C. Biswas
|
8 |
1993 |
8
🐬
|
|
🦁
|
Measurement of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Blood and Tissues: Clinical and Experimental Applications
9 auth.
S. Zucker,
Michelle Hymowitz,
Cathleen Conner,
H. Zarrabi,
A. Hurewitz,
L. Matrisian,
...
D. Boyd,
G. Nicolson,
Steve Montana
|
7 |
1999 |
7
🦁
|
|
🐜
|
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.
7 auth.
J. Sparano,
P. Bernardo,
P. Stephenson,
W. Gradishar,
J. Ingle,
S. Zucker,
...
N. Davidson
|
7 |
2004 |
7
🐜
|
